Why is this study being conducted?
Because currently approved therapies for social anxiety are not always ideal for every individual and sometimes have undesirable side effects, scientists continue to research drugs for individuals with social anxiety. Pharmaceutical companies use clinical studies like this one to learn more about investigational drugs before they are made available to the public.
This study is testing an investigational drug called cannabidiol (CBD) for adults with social anxiety who are between the ages of 18 and 75 years old. Doctors will compare CBD to a placebo to find out how well it works and how safe it is in individuals with social anxiety. A placebo is a substance that looks like the investigational drug but has no active drug in it.
What will happen in this study?
If you are eligible to enroll in the study, you will be randomly assigned to 1 of 3 treatment groups to receive either CBD or a placebo, given as an oral solution. Group assignment is done randomly (by chance; like drawing straws) by a computer. Neither you, nor the research doctor or coordinator, will know which treatment group you are in or whether you are receiving the investigational drug or the placebo. You will be in the study for approximately 16 weeks, and you will need to come to the clinic 9 times over this period.
Who is eligible to participate in this study?
To be eligible, you must be:
• 18 to 75 years old
• Experiencing social anxiety
• Able to give informed consent